Comparing short-term mortality between people with and without HIV admitted to the intensive care unit: A single-centre matched cohort study (2000-2019).

IF 2.8 3区 医学 Q2 INFECTIOUS DISEASES
HIV Medicine Pub Date : 2024-11-20 DOI:10.1111/hiv.13737
N Bakewell, T Kanitkar, O Dissanayake, M Symonds, S Rimmer, A Adlakha, M C Lipman, S Bhagani, B Agarwal, R F Miller, C A Sabin
{"title":"Comparing short-term mortality between people with and without HIV admitted to the intensive care unit: A single-centre matched cohort study (2000-2019).","authors":"N Bakewell, T Kanitkar, O Dissanayake, M Symonds, S Rimmer, A Adlakha, M C Lipman, S Bhagani, B Agarwal, R F Miller, C A Sabin","doi":"10.1111/hiv.13737","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The survival rate of people with HIV admitted to intensive care units (ICUs) is approaching that of people without HIV. We conducted a matched-cohort study of people with and without HIV admitted to ICU at a large hospital to compare short-term mortality, during 2000-2019.</p><p><strong>Methods: </strong>People with HIV were matched to people without HIV (1:2) on age, sex, admission year and Acute Physiology and Chronic Health Evaluation (APACHE)-II score. Applying logistic regression models fitted using independence estimating equations, we describe population-averaged associations of HIV with short-term (in-ICU, in-hospital) mortality during a patient's first admission to ICU, and explore whether these varied by year.</p><p><strong>Results: </strong>A total of 177 people with HIV were matched to 354 people without HIV (71.2% vs. 71.2% male; median age: 47 vs. 48 years, median APACHE-II: 18 vs. 17, median admission year: 2013 vs. 2013). Among people with HIV, 73.4% were on antiretroviral therapy, 51.2% had HIV-RNA ≤50 copies/mL and median CD4 T-cell count was 132 cells/ <math> <semantics><mrow><mi>μ</mi></mrow> <annotation>$$ \\upmu $$</annotation></semantics> </math> L. People with HIV had higher in-ICU (24.3% vs. 15.3%) and in-hospital (31.6% vs. 20.1%) mortality. People with HIV had 1.69-fold higher odds (95% confidence interval: 1.03-2.76) of in-ICU mortality and 1.86 (1.19-2.91) higher odds of in-hospital mortality than people without HIV, adjusted for age, sex, year and APACHE-II. There was no evidence that these associations varied by year (p-interaction-in-ICU = 0.90; p-interaction-in-hospital = 0.46).</p><p><strong>Conclusions: </strong>Our findings suggest that although outcomes have improved over time, people with HIV continue to have higher short-term in-ICU and in-hospital mortality following ICU admission compared with people without HIV with similar characteristics.</p>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/hiv.13737","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The survival rate of people with HIV admitted to intensive care units (ICUs) is approaching that of people without HIV. We conducted a matched-cohort study of people with and without HIV admitted to ICU at a large hospital to compare short-term mortality, during 2000-2019.

Methods: People with HIV were matched to people without HIV (1:2) on age, sex, admission year and Acute Physiology and Chronic Health Evaluation (APACHE)-II score. Applying logistic regression models fitted using independence estimating equations, we describe population-averaged associations of HIV with short-term (in-ICU, in-hospital) mortality during a patient's first admission to ICU, and explore whether these varied by year.

Results: A total of 177 people with HIV were matched to 354 people without HIV (71.2% vs. 71.2% male; median age: 47 vs. 48 years, median APACHE-II: 18 vs. 17, median admission year: 2013 vs. 2013). Among people with HIV, 73.4% were on antiretroviral therapy, 51.2% had HIV-RNA ≤50 copies/mL and median CD4 T-cell count was 132 cells/ μ $$ \upmu $$ L. People with HIV had higher in-ICU (24.3% vs. 15.3%) and in-hospital (31.6% vs. 20.1%) mortality. People with HIV had 1.69-fold higher odds (95% confidence interval: 1.03-2.76) of in-ICU mortality and 1.86 (1.19-2.91) higher odds of in-hospital mortality than people without HIV, adjusted for age, sex, year and APACHE-II. There was no evidence that these associations varied by year (p-interaction-in-ICU = 0.90; p-interaction-in-hospital = 0.46).

Conclusions: Our findings suggest that although outcomes have improved over time, people with HIV continue to have higher short-term in-ICU and in-hospital mortality following ICU admission compared with people without HIV with similar characteristics.

比较入住重症监护室的艾滋病病毒感染者和非艾滋病病毒感染者的短期死亡率:单中心匹配队列研究(2000-2019 年)。
目的:入住重症监护室(ICU)的艾滋病病毒感染者的存活率已接近非艾滋病病毒感染者的存活率。我们对一家大型医院重症监护室收治的艾滋病病毒感染者和非艾滋病病毒感染者进行了配对队列研究,以比较 2000-2019 年间的短期死亡率:方法:根据年龄、性别、入院年份和急性生理学和慢性健康评估(APACHE)-II 评分,将艾滋病毒感染者与非艾滋病毒感染者进行配对(1:2)。通过使用独立估计方程拟合的逻辑回归模型,我们描述了艾滋病病毒感染者与患者首次入住重症监护室期间的短期(重症监护室内、院内)死亡率的人群平均关系,并探讨了这些关系是否因年份而异:共有 177 名艾滋病病毒感染者与 354 名非艾滋病病毒感染者进行了配对(71.2% 对 71.2%,男性;年龄中位数:47 岁对 48 岁,APACHE-II 中位数:18 对 17,入院年份中位数:2013 年对 2013 年):2013年与2013年)。在艾滋病毒感染者中,73.4%的人正在接受抗逆转录病毒治疗,51.2%的人HIV-RNA ≤50 copies/mL,CD4 T细胞计数中位数为132 cells/ μ$ \upmu $$ L。艾滋病毒感染者的ICU内死亡率(24.3% 对 15.3%)和院内死亡率(31.6% 对 20.1%)较高。经年龄、性别、年份和 APACHE-II 调整后,HIV 感染者在重症监护室内的死亡率比非 HIV 感染者高 1.69 倍(95% 置信区间:1.03-2.76),在医院内的死亡率比非 HIV 感染者高 1.86 倍(1.19-2.91)。没有证据表明这些关联因年份而异(p-交互作用-ICU = 0.90;p-交互作用-医院 = 0.46):我们的研究结果表明,虽然随着时间的推移,结果有所改善,但与特征相似的非 HIV 感染者相比,HIV 感染者进入 ICU 后的短期 ICU 内和院内死亡率仍然较高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
HIV Medicine
HIV Medicine 医学-传染病学
CiteScore
5.10
自引率
10.00%
发文量
167
审稿时长
6-12 weeks
期刊介绍: HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV Medicine, embracing clinical, pharmocological, epidemiological, ethical, preclinical and in vitro studies. In addition, the journal will commission reviews and other feature articles. It will focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS. The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信